Oncodesign Precision Medicine (OPM) obtains €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101

Apr 17, 2024 - 18:12
 0  6
Oncodesign Precision Medicine (OPM) obtains  €5.6 million in public funding for its DEMOCRITE program dedicated to the clinical development of OPM-101

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow